These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27994951)

  • 21. Effects of growth hormone on insulin resistance and atherosclerotic risk factors in obese type 2 diabetic patients with poor glycaemic control.
    Ahn CW; Kim CS; Nam JH; Kim HJ; Nam JS; Park JS; Kang ES; Cha BS; Lim SK; Kim KR; Lee HC; Huh KB
    Clin Endocrinol (Oxf); 2006 Apr; 64(4):444-9. PubMed ID: 16584518
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of weight loss with or without exercise on abdominal fat and insulin resistance in obese individuals: a randomised clinical trial.
    Trussardi Fayh AP; Lopes AL; Fernandes PR; Reischak-Oliveira A; Friedman R
    Br J Nutr; 2013 Aug; 110(3):486-92. PubMed ID: 23302544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abdominal adiposity and liver fat content 3 and 12 months after gastric banding surgery.
    Heath ML; Kow L; Slavotinek JP; Valentine R; Toouli J; Thompson CH
    Metabolism; 2009 Jun; 58(6):753-8. PubMed ID: 19375765
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What are the physical characteristics associated with a normal metabolic profile despite a high level of obesity in postmenopausal women?
    Brochu M; Tchernof A; Dionne IJ; Sites CK; Eltabbakh GH; Sims EA; Poehlman ET
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1020-5. PubMed ID: 11238480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expressions of neuropeptide Y and Y1 receptor in subcutaneous and visceral fat tissues in normal weight and obese humans and their correlations with clinical parameters and peripheral metabolic factors.
    Sitticharoon C; Chatree S; Churintaraphan M
    Regul Pept; 2013 Aug; 185():65-72. PubMed ID: 23838112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pubertal alterations in growth and body composition. VI. Pubertal insulin resistance: relation to adiposity, body fat distribution and hormone release.
    Roemmich JN; Clark PA; Lusk M; Friel A; Weltman A; Epstein LH; Rogol AD
    Int J Obes Relat Metab Disord; 2002 May; 26(5):701-9. PubMed ID: 12032756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictors for cecal insertion time: the impact of abdominal visceral fat measured by computed tomography.
    Nagata N; Sakamoto K; Arai T; Niikura R; Shimbo T; Shinozaki M; Noda M; Uemura N
    Dis Colon Rectum; 2014 Oct; 57(10):1213-9. PubMed ID: 25203379
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between adiponectin, visfatin, and omentin in subcutaneous and visceral adipose tissues and serum, and correlations with clinical and peripheral metabolic factors.
    Sitticharoon C; Nway NC; Chatree S; Churintaraphan M; Boonpuan P; Maikaew P
    Peptides; 2014 Dec; 62():164-75. PubMed ID: 25453978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.
    Viljanen AP; Lautamäki R; Järvisalo M; Parkkola R; Huupponen R; Lehtimäki T; Rönnemaa T; Raitakari OT; Iozzo P; Nuutila P
    Ann Med; 2009; 41(2):152-60. PubMed ID: 18855190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients.
    Miyazaki Y; Mahankali A; Matsuda M; Mahankali S; Hardies J; Cusi K; Mandarino LJ; DeFronzo RA
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2784-91. PubMed ID: 12050251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of anthropometric, area- and volume-based assessment of abdominal subcutaneous and visceral adipose tissue volumes using multi-detector computed tomography.
    Maurovich-Horvat P; Massaro J; Fox CS; Moselewski F; O'Donnell CJ; Hoffmann U
    Int J Obes (Lond); 2007 Mar; 31(3):500-6. PubMed ID: 16953256
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Obesity in type 2 diabetes, its features and specificity].
    Xiang KS; Jia WP; Lu JX; Tang JL; Li J
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1768-72. PubMed ID: 15631769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome.
    Wajchenberg BL; Giannella-Neto D; da Silva ME; Santos RF
    Horm Metab Res; 2002; 34(11-12):616-21. PubMed ID: 12660870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of 11β-hydroxysteroid dehydrogenase type 1 in visceral and subcutaneous adipose tissues of patients with polycystic ovary syndrome is associated with adiposity.
    Mlinar B; Marc J; Jensterle M; Bokal EV; Jerin A; Pfeifer M
    J Steroid Biochem Mol Biol; 2011 Feb; 123(3-5):127-32. PubMed ID: 21147223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
    Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
    Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Is echography an adequate method for assessing the thickness of intra-abdominal fat? A comparison with computed tomography].
    Cucchi E; Piatti PM; Orena C; Pontiroli AE; Martino E; Paesano PL; Pozza G; Del Maschio A
    Radiol Med; 1997 Oct; 94(4):329-34. PubMed ID: 9465239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ultrasonography for the evaluation of visceral fat and the metabolic syndrome.
    Meriño-Ibarra E; Artieda M; Cenarro A; Goicoechea J; Calvo L; Guallar A; Civeira F
    Metabolism; 2005 Sep; 54(9):1230-5. PubMed ID: 16125535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance.
    Otake S; Takeda H; Suzuki Y; Fukui T; Watanabe S; Ishihama K; Saito T; Togashi H; Nakamura T; Matsuzawa Y; Kawata S
    Clin Cancer Res; 2005 May; 11(10):3642-6. PubMed ID: 15897559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.